Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 5:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2329–2352 of 2,691 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Normal saline solution Clear all

Conditions: Rotator Cuff Tear, Postoperative Pain
Interventions: Liposomal bupivacaine (LB); Drug
Lead sponsor: Orthopaedic & Neurosurgery Specialists; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Greenwich, Connecticut

Conditions: Total Knee Arthroplasty
Interventions: Liposome Bupivacaine, Bupivacaine; Drug
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Pain, Postoperative
Interventions: Ketolorac; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 90 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Beachwood, Ohio

Conditions: Transfusion Related Complication
Interventions: SNO, Normal Saline, Red Blood Cell; Drug
Lead sponsor: James Reynolds; Other
Eligibility: 18 Years to 35 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Amyloidosis; Systemic
Interventions: AT-02, AT-02 (Placebo); Drug · Other
Lead sponsor: Attralus, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 6
States / cities: Overland Park, Kansas • Baltimore, Maryland • Kansas City, Missouri + 3 more

Conditions: Hyperlactatemia
Interventions: Lactated Ringer Solution, Normal Saline; Drug
Lead sponsor: University Medical Center of Southern Nevada; Other
Eligibility: 18 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Pain, Postoperative, Opioid Use
Interventions: Bupivacaine; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Baltimore, Maryland • Columbia, Maryland

Conditions: Urinary Tract Infection, Recurrent
Interventions: phage therapy, control; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Scoliosis
Interventions: Bupivacaine, Normal Saline; Drug
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: 8 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Asthma
Interventions: RNS60, Normal Saline; Drug
Lead sponsor: Revalesio Corporation; Industry
Eligibility: 18 Years to 50 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Dental Pain
Interventions: Bupivacaine liposome, Placebo; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Hepatorenal Syndrome
Interventions: Terlipressin, Placebo; Drug
Lead sponsor: Mallinckrodt; Industry
Eligibility: 18 Years and older
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 71
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 51 more

Conditions: Middle East Respiratory Syndrome Coronavirus
Interventions: SAB-301, Normal (9%) Saline; Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pain, Acute
Interventions: Intravenous oxytocin, Intravenous placebo, Intranasal oxytocin, Intranasal placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Postoperative Pain
Interventions: Bupivacaine, Saline Solution; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Fresno, California

Conditions: Respiratory Syncytial Virus
Interventions: Azithromycin 10 mg, Azithromycin 20mg, Placebo; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: Up to 16 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Surgery, Analgesia
Interventions: Liposomal bupivacaine, Thoracic epidural analgesia (bupivacaine); Drug · Other
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Female only
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Joint Replacement Surgery
Interventions: Normal Saline 10 mL Injection; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: Not listed
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Tourette Syndrome
Interventions: levodopa solution 2mg/ml for i.v. use, placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 55 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pain, Touch
Interventions: Placebo, Naloxone; Other · Drug
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Tendinopathy, Tendinosis
Interventions: Resection (removal) of the degenerative tissue using the Hydrocision TenJet system, Hydrocision Tenjet System; Procedure · Device
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years to 70 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 7
States / cities: Redwood City, California • Coral Springs, Florida • Baton Rouge, Louisiana + 4 more

Conditions: Posttraumatic Headache, Posttraumatic Stress Disorder
Interventions: Group A active comparator, Group B active comparator, Group C Experimental, Group D Placebo Comparator; Procedure · Drug · Combination Product + 1 more
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 3
States / cities: Chicago, Illinois • Bethesda, Maryland • Fort Bragg, North Carolina

Conditions: Neuropathic Pain
Interventions: Ondansetron 16 mg with Tariquidar, Ondansetron 16 mg with Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Atherosclerosis
Interventions: Phlebotomy; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 40 Years to 70 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Liposomal Bupivacaine for Pain Control After Rotator Cuff Repair

Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty

Ketolorac Versus Saline at Laparoscopic Incision Sites

S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion

Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis

Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?

Intra-operative Uterosacral Ligament Bupivacaine Injection During Minimally Invasive Hysterectomy

Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients

Continuous Local Infusion of Anesthetic at the Incisional Site for Scoliosis Surgery

Pilot Study of RNS60 in Allergen-induced Bronchoconstriction

Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults

Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain

Peripheral Nerve Blocks for Major Lower Extremity Amputations

Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children

Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery

Reversal of Spinal Anesthesia Residual Motor Block Via Intrathecal Catheter

Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)

Sensory and Opioid Mechanisms of Affective Touch

Treatment of Tendinosis Using the TenJet Hydroresection System

Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSD

Tariquidar-ondansetron Combination in Neuropathic Pain

Serial Phlebotomy in Voluntary Blood Donors